相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-23: A key cytokine in inflammatory diseases
Emilie Duvallet et al.
ANNALS OF MEDICINE (2011)
The IL-17 pathway as a major therapeutic target in autoimmune diseases
Yan Hu et al.
YEAR IN IMMUNOLOGY (2011)
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
George D. Kitas et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Adipocytokines as Driving Forces in Rheumatoid Arthritis and Related Inflammatory Diseases?
E. Neumann et al.
ARTHRITIS AND RHEUMATISM (2011)
Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2011)
Increased Sensitivity to Apoptosis Induced by Methotrexate Is Mediated by JNK
Charles F. Spurlock et al.
ARTHRITIS AND RHEUMATISM (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
The burden of illness of rheumatoid arthritis
Annelies Boonen et al.
CLINICAL RHEUMATOLOGY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Does Anti-Tumor Necrosis Factor-α Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data
Edward C. Keystone
JOURNAL OF RHEUMATOLOGY (2011)
Induction of immune tolerance in the treatment of rheumatoid arthritis
Salvatore Albani et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Interleukin-33 biology with potential insights into human diseases
Gaby Palmer et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
Pablo Engel et al.
PHARMACOLOGICAL REVIEWS (2011)
New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors
M. Gema Bonilla-Hernan et al.
RHEUMATOLOGY (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Targeting the B Cell in Rheumatoid Arthritis
Stanley B. Cohen
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
Peter C. Taylor
CURRENT OPINION IN PHARMACOLOGY (2010)
Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
Axel J. Hueber et al.
JOURNAL OF IMMUNOLOGY (2010)
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven et al.
JOURNAL OF RHEUMATOLOGY (2010)
Improving the Routine Management of Rheumatoid Arthritis: The Value of Tight Control
Philip J. Mease
JOURNAL OF RHEUMATOLOGY (2010)
TNF receptor 2 pathway: drug target for autoimmune diseases
Denise Faustman et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
IL-1 pathways in inflammation and human diseases
Cem Gabay et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Interleukin-1β (IL-1β) Processing Pathway
Axel Weber et al.
SCIENCE SIGNALING (2010)
Outcomes in Recent-Onset Inflammatory Polyarthritis Differ According to Initial Titers, Persistence Over Time, and Specificity of the Autoantibodies
Marie-Caroline Guzian et al.
ARTHRITIS CARE & RESEARCH (2010)
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
M. H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interleukin-6 Blockade Suppresses Autoimmune Arthritis in Mice by the Inhibition of Inflammatory Th17 Responses
Minoru Fujimoto et al.
ARTHRITIS AND RHEUMATISM (2008)
Immune-mediated pathways in chronic inflammatory arthritis
Claire L. Gorman et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
Norihiro Nishimoto et al.
BLOOD (2008)
(Re)defining biopharmaceutical
Ronald A. Rader
NATURE BIOTECHNOLOGY (2008)
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
M. Hashizume et al.
RHEUMATOLOGY (2008)
T cells in rheumatoid arthritis
Andrew P. Cope
ARTHRITIS RESEARCH & THERAPY (2008)
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results
A. Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
J. A. M. Wessels et al.
RHEUMATOLOGY (2008)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Cytokines in the pathogenesis of rheumatoid arthritis
Iain B. McInnes et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis
Axel Finckh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
T-cell-targeted therapies in rheumatoid arthritis
CM Weyand et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis - A two-year prospective study (the DAMAGE study cohort)
BW Kirkham et al.
ARTHRITIS AND RHEUMATISM (2006)
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial
YPM Goekoop-Ruiterman et al.
ARTHRITIS AND RHEUMATISM (2005)
Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis
BN Cronstein
PHARMACOLOGICAL REVIEWS (2005)
The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models
E Lubberts et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis
G Boire et al.
ARTHRITIS RESEARCH & THERAPY (2005)
T cells, fibroblast-like synoviocytes, and granzyme B plus cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis
MC Kraan et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
C Grigor et al.
LANCET (2004)
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
S Paust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody - A multicenter, double-blind, placebo-controlled trial
N Nishimoto et al.
ARTHRITIS AND RHEUMATISM (2004)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
TNF receptor subtype signalling: Differences and cellular consequences
DJ MacEwan
CELLULAR SIGNALLING (2002)
T cell activation in rheumatoid synovium is B cell dependent
S Takemura et al.
JOURNAL OF IMMUNOLOGY (2001)
Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.
EHS Choy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
